Drug triggers and clinic of acute generalized exanthematous pustulosis (AGEP): a literature case series of 297 patients

E Vallejo-Yagüe, A Martinez-De la Torre… - Journal of Clinical …, 2022 - mdpi.com
Acute generalized exanthematous pustulosis (AGEP) is a rare skin reaction, commonly
caused by drugs. Available evidence mostly relies on small studies or case reports. We …

Acute generalized exanthematous pustulosis: clinical features, differential diagnosis, and management

R Parisi, H Shah, AA Navarini, B Muehleisen… - American Journal of …, 2023 - Springer
Acute generalized exanthematous pustulosis (AGEP) is a rare, acute, severe cutaneous
adverse reaction mainly attributed to drugs, although other triggers, including infections …

[PDF][PDF] The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events

P Gisondi, S Piaserico, C Bordin, F Bellinato… - Clin Exp …, 2021 - clinexprheumatol.org
Hydroxychloroquine is an established therapy for several rheumatological disorders, and
very recently it has been proposed as a possible treatment for the new coronavirus disease …

[PDF][PDF] Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19

J Delaleu, B Deniau, M Battistella, A de Masson… - The Journal of Allergy …, 2020 - Elsevier
Hydroxychloroquine is now commonly used off-label for the treatment of COVID-19 in
combination with drugs, at doses and in populations where it is not typically used. We …

COVID-19: The experience from Iran

M Daneshpazhooh, HR Mahmoudi - Clinics in Dermatology, 2021 - Elsevier
The first cases of coronavirus disease 2019 (COVID-19) in Iran were detected on February
19, 2020. Soon the entire country was hit with the virus. Although dermatologists were not …

The first pediatric case of acute generalized exanthematous pustulosis caused by hydroxychloroquine

G Liccioli, E Marrani, T Giani, G Simonini, S Barni… - Pharmacology, 2019 - karger.com
Introduction: Acute generalized exanthematous pustulosis (AGEP) is a generalized, non-
follicular sterile pustular rash, categorized as a severe cutaneous adverse reaction, which …

Hydroxychloroquine‐induced acute generalized exanthematous pustulosis: a series of seven patients and review of the literature

R Chaabouni, E Bahloul, M Ennouri… - International Journal …, 2021 - Wiley Online Library
Background Hydroxychloroquine (HCQ)‐induced acute generalized exanthematous
pustulosis (AGEP) is poorly described in the literature. The aim of our study was to …

[HTML][HTML] Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID‐19

T Enos, HS Jeong, T Vandergriff, HT Jacobe… - Dermatologic …, 2020 - ncbi.nlm.nih.gov
Dear Editor, Acute generalized exanthematous pustulosis (AGEP) is a severe cutaneous
adverse reaction. Rare cases secondary to hydroxychloroquine (HCQ) are documented in …

Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report

I Coleman, G Ruiz, S Brahmbhatt… - Journal of Medical Case …, 2020 - Springer
Abstract Background Since the World Health Organization declared a global pandemic due
to the novel coronavirus disease2019, there have been targeted efforts to establish …

[HTML][HTML] Comment on “Generalized pustular figurate erythema: a newly delineated severe cutaneous drug reaction linked with hydroxychloroquine”: report of a COVID …

A Suarez‐Valle, D Fernandez‐Nieto… - Dermatologic …, 2020 - ncbi.nlm.nih.gov
We read with great interest the article by Schwartz et al. 1 about generalized pustular
figurate erythema (GPFE) related to hydroxychloroquine. The rapid spread of the new …